Medicare Enrolled

Dr. Tara Ezzell, M.D.

Dermatology · Gainesville, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1600 SW ARCHER RD, Gainesville, FL 32610
3522656647
In practice since 2006 (19 years)
NPI: 1750399051 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ezzell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ezzell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ezzell

Dr. Tara Ezzell is a dermatology specialist in Gainesville, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ezzell performed 12,383 Medicare services across 6,977 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ezzell received a total of $7,127 from 45 pharmaceutical and/or device companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ezzell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in FL $7,127 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 92160 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
12,383
Medicare services
Top 9% in FL for dermatology
6,977
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~652 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 4,305 $5 $20
Office visit, established patient (20-29 min) 1,907 $61 $105
Destruction of precancerous skin growth, 1 1,487 $37 $100
Office visit, established patient (30-39 min) 1,223 $87 $150
Skin biopsy, tangential 799 $65 $125
Destruction of skin growths (warts/lesions), 1-14 500 $75 $130
Office visit, established patient (10-19 min) 430 $40 $70
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 194 $115 $205
Biopsy of related skin growth, each additional growth 185 $39 $66
New patient office visit (30-44 min) 163 $73 $125
Steroid injection (triamcinolone) 121 $1 $6
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm 104 $87 $130
New patient office visit (45-59 min) 82 $114 $190
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 75 $132 $255
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm 70 $92 $170
Destruction of precancer skin growth, 15 or more growths 57 $133 $240
Shaving of skin growth of body, arms, or legs, 0.5 cm or less 56 $57 $105
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 52 $228 $350
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 52 $129 $215
Injection into skin growth, 1-7 growths 43 $34 $70
Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm 41 $100 $155
New patient office or other outpatient visit, 15-29 minutes 41 $42 $85
Biopsy of ear 39 $50 $125
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 36 $100 $285
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm 35 $143 $258
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm 30 $108 $195
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm 26 $88 $130
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less 26 $79 $125
Application of light with debridement to destroy precancer skin growth 26 $185 $325
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 25 $93 $150
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less 24 $67 $120
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm 24 $125 $225
Complicated or multiple drainage of skin abscess 19 $153 $220
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) 19 $306 $450
Punch biopsy, first skin growth 17 $76 $155
Simple or single drainage of skin abscess 14 $100 $130
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less 14 $199 $285
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 11 $89 $155
Destruction of skin growth, 15 or more growths 11 $97 $155
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,127
Total received (2018-2024)
Avg $1,018/year across 7 years
Top 23% in FL for dermatology
45
Companies
273
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,707 (94.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$420 (5.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,159
2023
$1,152
2022
$1,564
2021
$767
2020
$442
2019
$1,181
2018
$862

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$796
ABBVIE INC.
$616
Regeneron Healthcare Solutions, Inc.
$550
Lilly USA, LLC
$428
Novartis Pharmaceuticals Corporation
$404
PFIZER INC.
$348
AbbVie, Inc.
$331
LEO Pharma Inc.
$301
Incyte Corporation
$284
Sun Pharmaceutical Industries Inc.
$268
Almirall LLC
$261
AbbVie Inc.
$221
E.R. Squibb & Sons, L.L.C.
$208
GENZYME CORPORATION
$196
Galderma Laboratories, L.P.
$182
Ortho Dermatologics, a division of Bausch Health US, LLC
$176
Sebela Pharmaceuticals Inc.
$129
Janssen Scientific Affairs, LLC
$126
MAYNE PHARMA COMMERCIAL LLC
$124
Celgene Corporation
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$100
Amgen Inc.
$90
Smith+Nephew, Inc.
$85
Arcutis Biotherapeutics, Inc.
$77
Sandoz Inc.
$70
Genentech USA, Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
UCB, Inc.
$60
Surgical Specialties Corporation (US), Inc.
$55
DUSA Pharmaceuticals, Inc.
$44
Smith & Nephew, Inc.
$42
EPI Health, LLC
$38
Allergan Inc.
$30
Allergan, Inc.
$28
Helsinn Therapeutics (U.S.), Inc.
$26
Dermavant Sciences, Inc.
$26
Verrica Pharmaceuticals Inc.
$25
MAYNE PHARMA INC.
$24
Journey Medical Corporation
$23
VYNE Pharmaceuticals Inc.
$22
ORGANOGENESIS INC.
$20
Biofrontera Inc.
$19
SANOFI-AVENTIS U.S. LLC
$17
Kyowa Kirin, Inc.
$13
Bioventus LLC
$13
Top 3 companies account for 27.5% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · ARAZLO · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bensal HP · Bimzelx · CIBINQO · COLLAGENASE SANTYL · COSENTYX · Cimzia · DERMATITIS - DISEASE · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · GRAFIX PL · HUMIRA · Humira · ILUMYA · Ilumya · KERYDIN · LIBTAYO · LITFULO · NAFTIN · ODOMZO · OPZELURA · ORACEA · Odomzo · Otezla · POTELIGEO · PRAMOSONE · Puraply · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Santyl · Seysara · Skyrizi · Sotyktu · Surgical wound closure product · TALTZ · TREMFYA · TWYNEO · Tremfya · VALCHLOR · VTAMA · Winlevi · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $58 per 100 Medicare services performed
Looking for a dermatology specialist in Gainesville?
Compare dermatologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
38
Per 100K population
13.5
County median income
$59,659
Nearest hospital
UF HEALTH SHANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ezzell is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ezzell experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Ezzell performed 4,305 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ezzell receive payments from pharmaceutical companies?
Yes. Dr. Ezzell received a total of $7,127 from 45 companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ezzell's costs compare to other dermatologists in Gainesville?
Dr. Ezzell's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ezzell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →